Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Detection of Significant Association Between Variants in Cannabinoid Receptor 1 Gene (CNR1) and Personality in African-American Population.

Yao Y, Xu Y, Zhao J, Ma Y, Su K, Yuan W, Ma JZ, Payne TJ, Li MD.

Front Genet. 2018 Jun 14;9:199. doi: 10.3389/fgene.2018.00199. eCollection 2018.

2.

New findings in pharmacogenetics of schizophrenia.

Zai CC, Tiwari AK, Zai GC, Maes MS, Kennedy JL.

Curr Opin Psychiatry. 2018 May;31(3):200-212. doi: 10.1097/YCO.0000000000000417.

PMID:
29528898
3.

Accessing Gene Expression in Treatment-Resistant Schizophrenia.

Moretti PN, Ota VK, Gouvea ES, Pedrini M, Santoro ML, Talarico F, Spindola LM, Carvalho CM, Noto C, Xavier G, Brietzke E, Gadelha A, Bressan R, Mari J, Belangero S.

Mol Neurobiol. 2018 Aug;55(8):7000-7008. doi: 10.1007/s12035-018-0876-4. Epub 2018 Jan 26.

PMID:
29374346
4.

The effect of interactions between genetics and cannabis use on neurocognition. A review.

Cosker E, Schwitzer T, Ramoz N, Ligier F, Lalanne L, Gorwood P, Schwan R, Laprévote V.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:95-106. doi: 10.1016/j.pnpbp.2017.11.024. Epub 2017 Nov 28. Review.

PMID:
29191570
5.

Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet.

Delis F, Rosko L, Shroff A, Leonard KE, Thanos PK.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):268-280. doi: 10.1016/j.pnpbp.2017.06.005. Epub 2017 Jun 13.

PMID:
28619471
6.

HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals.

Večeřa J, Bártová E, Krejčí J, Legartová S, Komůrková D, Rudá-Kučerová J, Štark T, Dražanová E, Kašpárek T, Šulcová A, Dekker FJ, Szymanski W, Seiser C, Weitzer G, Mechoulam R, Micale V, Kozubek S.

J Cell Physiol. 2018 Jan;233(1):530-548. doi: 10.1002/jcp.25914. Epub 2017 May 3.

PMID:
28300292
7.

A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.

D'Addario C, Micale V, Di Bartolomeo M, Stark T, Pucci M, Sulcova A, Palazzo M, Babinska Z, Cremaschi L, Drago F, Carlo Altamura A, Maccarrone M, Dell'Osso B.

Schizophr Res. 2017 Oct;188:132-140. doi: 10.1016/j.schres.2017.01.022. Epub 2017 Jan 17.

PMID:
28108228
8.

The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.

Gouvêa ES, Santos AF Filho, Ota VK, Mrad V, Gadelha A, Bressan RA, Cordeiro Q, Belangero SI.

Braz J Psychiatr. 2017 Apr-Jun;39(2):160-171. doi: 10.1590/1516-4446-2016-1969. Epub 2017 Jan 12. Review.

9.

The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801.

Kruk-Slomka M, Budzynska B, Slomka T, Banaszkiewicz I, Biala G.

Neurotox Res. 2016 Nov;30(4):658-676. Epub 2016 Aug 30.

10.

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.

Lanning RK, Zai CC, Müller DJ.

Pharmacogenomics. 2016 Aug;17(12):1339-51. doi: 10.2217/pgs.16.26. Epub 2016 Jul 29. Review.

PMID:
27469238
11.

Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience.

Loureiro M, Kramar C, Renard J, Rosen LG, Laviolette SR.

Biol Psychiatry. 2016 Aug 1;80(3):216-25. doi: 10.1016/j.biopsych.2015.10.016. Epub 2015 Oct 31.

PMID:
26681496
12.

The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway.

Xie J, Gizatullin R, Vukojevic V, Leopardi R.

Neuroscience. 2015 Dec 3;310:723-30. doi: 10.1016/j.neuroscience.2015.10.012. Epub 2015 Oct 22.

PMID:
26475744
13.

Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms.

Suárez-Pinilla P, Roiz-Santiañez R, Ortiz-García de la Foz V, Guest PC, Ayesa-Arriola R, Córdova-Palomera A, Tordesillas-Gutierrez D, Crespo-Facorro B.

Psychiatry Res. 2015 Aug 30;233(2):112-9. doi: 10.1016/j.pscychresns.2015.05.005. Epub 2015 May 21.

PMID:
26071625
14.

Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction.

Loureiro M, Renard J, Zunder J, Laviolette SR.

Neuropsychopharmacology. 2015 May;40(6):1436-47. doi: 10.1038/npp.2014.329. Epub 2014 Dec 16.

15.

Dissociable deficits of executive function caused by gestational adversity are linked to specific transcriptional changes in the prefrontal cortex.

Grissom NM, Herdt CT, Desilets J, Lidsky-Everson J, Reyes TM.

Neuropsychopharmacology. 2015 May;40(6):1353-63. doi: 10.1038/npp.2014.313. Epub 2014 Nov 24.

16.

Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.

Volk DW, Eggan SM, Horti AG, Wong DF, Lewis DA.

Schizophr Res. 2014 Oct;159(1):124-9. doi: 10.1016/j.schres.2014.07.017. Epub 2014 Aug 5.

17.

Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population.

Bae JS, Kim JY, Park BL, Kim JH, Kim B, Park CS, Kim BJ, Lee CS, Lee M, Choi WH, Shin TM, Hwang J, Shin HD, Woo SI.

Psychiatr Genet. 2014 Oct;24(5):225-9. doi: 10.1097/YPG.0000000000000047.

PMID:
25014618
18.

The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.

Sánchez-Blázquez P, Rodríguez-Muñoz M, Herrero-Labrador R, Burgueño J, Zamanillo D, Garzón J.

Int J Neuropsychopharmacol. 2014 Dec;17(12):1943-55. doi: 10.1017/S1461145714000029. Epub 2014 Jan 31.

PMID:
24485144
19.

The role of cannabinoid 1 receptor expressing interneurons in behavior.

Brown JA, Horváth S, Garbett KA, Schmidt MJ, Everheart M, Gellért L, Ebert P, Mirnics K.

Neurobiol Dis. 2014 Mar;63:210-21. doi: 10.1016/j.nbd.2013.11.001. Epub 2013 Nov 13.

20.

HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity.

Vicente-Sánchez A, Sánchez-Blázquez P, Rodríguez-Muñoz M, Garzón J.

Mol Brain. 2013 Oct 5;6:42. doi: 10.1186/1756-6606-6-42.

Supplemental Content

Loading ...
Support Center